Monday - Friday 9am - 5pm GMT
  Monday - Friday 9am - 5pm GMT

Fibromyalgia sufferers find much needed pain relief through Whole Body Cryotherapy

Scientific research identifies that six whole body cryotherapy sessions at -130 °C can significantly reduce pain and disease activity.

A recently published scientific research article[i] has highlighted the beneficial use of whole-body cryotherapy for sufferers of fibromyalgia. Fibromyalgia is a debilitating condition that causes extreme tiredness and widespread pain across the body as well as consequences on the mental health and quality of life for sufferers. While it is not yet known exactly why fibromyalgia occurs, it is thought there could be several causative factors such as a chemical imbalance in the body, genetics, abnormal pain messages to the brain or strong emotional triggers which could include, for example, the loss of a loved one. Recent, clinical trials[ii] have, however, found evidence that the condition is associated with irregular levels of pro-inflammatory cytokines. According to the NHS website, estimates suggest that nearly 1 in 20 people may be affected by the conditions to some degree. Sadly, there is no cure for the condition, but the symptoms can be managed.

Whole Body Cryotherapy involves exposing the body to temperatures as low as -130°C for a period of up to 3 minutes. The therapy is delivered in a specially designed cryogenic chamber where the air is supercooled, and users stand in the chamber under the guidance of a trained operator. The whole-body cryotherapy sessions can be taken at regular intervals over a period of weeks.

The study concluded that serial whole body cryotherapy sessions are a fast-acting and effective treatment for suffers from fibromyalgia. When compared with a healthy control group, fibromyalgia patients showed notably different cytokine levels and reported a significant reduction in pain and disease activity after three and six whole body cryotherapy sessions. It’s believed that an alteration in cytokine levels accounts for the reported benefits and that the changes in cytokine levels occur as the direct result of the patients’ exposure to the extreme cold, thereby establishing whole body cryotherapy as a fast-acting and effective, and much-needed treatment for fibromyalgia.

The research involved 23 fibromyalgia sufferers and 30 healthy controls participating in six sessions of whole-body cryotherapy at -130 °C. The research was conducted by

  • Phillip Klemm– Department of Rheumatology, Immunology, Osteology and Physical Medicine, Justus-Liebig-University Giessen, Campus Kerckhoff, Bad Nauheim, Germany
  • Johanna BeckerIris AykaraGabriel DischereitElena Neumann , Ulf Müller-Ladner , & Uwe Lange  – Department of Rheumatology, Immunology, Osteology and Physical Medicine, Justus-Liebig-University Giessen, Campus Kerckhoff, Bad Nauheim, Germany.
  • Thomas Asendorf – Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany.

 

CryoAction Chief Executive Officer, Ian Saunders commented:

“Fibromyalgia can be an extremely debilitating condition, with an estimated 1.5 to 2 million people in the UK being affected. We know from our clients that more and more sufferers of fibromyalgia are turning to extreme cold treatment as an effective way of managing their pain and improving their quality of life.

It’s fantastic to see this study highlights just how powerful regular whole body cryotherapy sessions can be in bringing about drug-free pain relief and will be much welcomed news for sufferers of the condition”

CryoAction cryotherapy chambers are available in various locations throughout the UK with retained operators available to administer whole body cryotherapy sessions

[i] Serial whole-body cryotherapy in fibromyalgia is effective and alters cytokine profiles –  Philipp Klemm 1, Johanna Becker 2, Iris Aykara 2, Thomas Asendorf 3, Gabriel Dischereit 2, Elena Neumann 2, Ulf Müller-Ladner 2, Uwe Lange 2 ( https://pubmed.ncbi.nlm.nih.gov/33436106/)

 

[ii] Fibromyalgia and cytokines – Ignasi Rodriguez-Pintó , Nancy Agmon-Levin , Amital Howard, Yehuda Shoenfeld (https://www.sciencedirect.com/science/article/abs/pii/S0165247814000133?via%)

837857143471550
We are using cookies to give you the best experience. You can find out more about which cookies we are using or switch them off in privacy settings.
AcceptPrivacy Settings

GDPR

  • Privacy Policy
  • Google Analytics
  • Video Content
  • LinkedIn
  • Facebook & Instagram
  • Hotjar

Privacy Policy

We use your data to provide and improve the Service. By using the Service, you agree to the collection and use of information in accordance with this policy. Unless otherwise defined in this Privacy Policy, terms used in this Privacy Policy have the same meanings as in our Terms and Conditions, accessible from https://cryoaction.com

You read our full policy here: https://cryoaction.com/privacy-policy/

Google Analytics

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Video Content

This website use video embedding code from Vimeo. This service provider may collect the data from you for marketing purposes.

LinkedIn

This website uses LinkedIn website tracking for campaign performance evaluation and remarketing purposes.

Keeping this cookie enabled helps us to improve our website and your experience with us.

For more information on these cookies please visit LinkedIn: https://www.linkedin.com/help/lms/answer/a420533

Facebook & Instagram

This website uses Facebook & Instagram website tracking for campaign performance evaluation and marketing purposes.

Keeping this cookie enabled helps us to improve our website and your experience with us.

Hotjar

This helps us to understand how the website is used so we can make improvements to its usability.